Bond, A. (2006). Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus. Baylor Health Care System.
Citación estilo ChicagoBond, Aaron. Exenatide (Byetta) As a Novel Treatment Option for Type 2 Diabetes Mellitus. Baylor Health Care System, 2006.
Cita MLABond, Aaron. Exenatide (Byetta) As a Novel Treatment Option for Type 2 Diabetes Mellitus. Baylor Health Care System, 2006.
Precaución: Estas citas no son 100% exactas.